A detailed history of Private Capital Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Private Capital Group, LLC holds 6 shares of NVAX stock, worth $51. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 43 86.05%
Holding current value
$51
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$36.28 - $75.29 $1,342 - $2,785
-37 Reduced 86.05%
6 $0
Q4 2021

Jan 24, 2022

SELL
$134.56 - $217.97 $1,076 - $1,743
-8 Reduced 15.69%
43 $6,000
Q3 2021

Oct 13, 2021

BUY
$177.8 - $270.58 $2,311 - $3,517
13 Added 34.21%
51 $11,000
Q2 2021

Jul 26, 2021

SELL
$121.0 - $257.67 $1,936 - $4,122
-16 Reduced 29.63%
38 $8,000
Q1 2021

Apr 12, 2021

SELL
$112.98 - $319.93 $9,490 - $26,874
-84 Reduced 60.87%
54 $10,000
Q4 2020

Jan 26, 2021

BUY
$78.74 - $139.5 $10,866 - $19,251
138 New
138 $15,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.